Works by Xie, Si

Results: 113
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x
    By:
    • Yuan, Li;
    • Jia, Guo-Dong;
    • Lv, Xiao-Fei;
    • Xie, Si-Yi;
    • Guo, Shan-Shan;
    • Lin, Da-Feng;
    • Liu, Li-Ting;
    • Luo, Dong-Hua;
    • Li, Yi-Fu;
    • Deng, Shen-Wen;
    • Guo, Ling;
    • Zeng, Mu-Sheng;
    • Cai, Xiu-Yu;
    • Liu, Sai-Lan;
    • Sun, Xue-Song;
    • Li, Xiao-Yun;
    • Li, Su-Chen;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1024333
    By:
    • Li, Minghui;
    • Zhang, Luxue;
    • Xie, Si;
    • Sun, Fangfang;
    • Zeng, Zhan;
    • Deng, Wen;
    • Jiang, Tingting;
    • Bi, Xiaoyue;
    • Lin, Yanjie;
    • Yang, Liu;
    • Lu, Yao;
    • Shen, Ge;
    • Liu, Ruyu;
    • Wu, Shuling;
    • Chang, Min;
    • Hu, Leiping;
    • Dong, Jianping;
    • Yi, Wei;
    • Xie, Yao
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50